Berberis integerrima ameliorates insulin resistance in high- fructose-fed insulin-resistant rats

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 187

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-20-10_004

تاریخ نمایه سازی: 28 مهر 1400

چکیده مقاله:

Objective(s): This study was aimed to investigate the effect of Berberis integerrima (B. integerrima) extract on insulin sensitivity in high-fructose-fed insulin-resistant rats. Materials and Methods: Experimental rats were randomly divided into two groups: the control group was fed a regular chow diet while other group fed with a high-fructose diet for ۸ weeks. After the first six weeks, the animals were treated with B. integerrima extract or pioglitazone for two weeks. Insulin and adiponectin levels were measured by ELISA. Additionally, Insulin resistance was calculated using a Homeostasis Model Assessment of Insulin resistance (HOMA-IR). The plasma free fatty acid (FFA) profile was obtained by gas chromatography. PPARγ and GLUT۴ gene expression were assessed by real-time polymerase chain reaction (PCR) and western-blotting. Results: Comparing the B. integerrima treated group with the control group, weight gain (P=۰.۰۰۹) and levels of insulin (P=۰.۰۰۱), blood glucose (P<۰.۰۰۰۱), and HOMA-IR (P<۰.۰۰۰۱) were significantly reduced. Additionally, the adiponectin concentration was significantly increased (P<۰.۰۰۰۱). Among the FFA fractions, the mean concentration of palmitoleic acid and stearic acid in the B. integerrima group were significantly higher than the control group (P<۰.۰۰۰۱ and P=۰.۰۰۵, respectively). However, there was no significant difference at the mRNA and protein level of GLUT۴ and PPAR-γ between B. integerrima treated group and control group. Conclusion: The study findings revealed that B. integerrima might be a protective candidate against Type ۲ diabetes/insulin resistance through direct insulin-like effect and an increase in adiponectin levels. However, the mechanism of B. integerrima was independent of GLUT۴ and PPARγ.

نویسندگان

Hossein Fallah

Department of Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Hamed Akbari

Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Moslem Abolhassani

Student Research Committee, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Abbas Mohammadi

Department of Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Ahmad Gholamhosseinian

Department of Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Soares FL, de Oliveira Matoso R, Teixeira LG, Menezes Z, ...
  • Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin ...
  • Araújo TG, de Oliveira AG, Vecina JF, Marin RM, Franco ...
  • Joo H, Kim CT, Kim IH, Kim Y. Anti-obesity effects ...
  • Xu H, Barnes GT, Yang Q, Tan G, Yang D, ...
  • Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, ...
  • Kahn BB, Flier JS. On diabetes : insulin resistance Obesity and ...
  • Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and ...
  • Jung UJ, Choi MS. Obesity and its metabolic complications: the ...
  • Goossens GH. The role of adipose tissue dysfunction in the ...
  • Kalupahana NS, Moustaid-Moussa N, Claycombe KJ. Immunity as a link ...
  • Esfahani M, Movahedian A, Baranchi M, Goodarzi MT. Adiponectin: an ...
  • Caselli C. Role of adiponectin system in insulin resistance. Mol ...
  • Li L, Wu L, Wang C, Liu L, Zhao Y. ...
  • Dupont J, Chabrolle C, Ramé C, Tosca L, Coyral-Castel S. ...
  • Maebuchi M, Machidori M, Urade R, Ogawa T, Moriyama T. ...
  • Boden G. Obesity, insulin resistance and free fatty acids. Curr ...
  • Capurso C, Capurso A. From excess adiposity to insulin resistance: ...
  • Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E. ...
  • Hotamisligil GS. Inflammation and metabolic disorders ۱. Nature ۲۰۰۶; ۴۴۴:۸۶۰–۸۶۷ ...
  • Mohammadi A, Gholamhoseinian A, Fallah H. Zataria multiflora increases insulin ...
  • Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and ...
  • Leguisamo NM, Lehnen AM, Machado UF, Okamoto MM, Markoski MM, ...
  • Butler M, McKay RA, Popoff IJ, Gaarde WA, Witchell D, ...
  • Westerblad H, Bruton JD, Katz A. Skeletal muscle: Energy metabolism, ...
  • Kajiya T, Ho C, Wang J, Vilardi R, Kurtz TW. ...
  • Lee JY, Hashizaki H, Goto T, Sakamoto T, Takahashi N, ...
  • Papaetis GS, Orphanidou D, Panagiotou TN. Thiazolidinediones and type ۲ ...
  • Taylor C, Hobbs FDR. Type ۲ diabetes, thiazolidinediones, and cardiovascular ...
  • Papaetis GS, Orphanidou D, Panagiotou TN. Thiazolidinediones and type ۲ ...
  • Seymour EM, Tanone II, Urcuyo-Llanes DE, Lewis SK, Kirakosyan A, ...
  • Lewis JD, Ferrara A, Peng T, Hedderson M, Bilker WB, ...
  • Ahvazi M, Akbarzadeh M, Khalighi Sigaroodi F, Kohandel A. Introduce ...
  • Alemardan A, Asadi W, Rezaei M, Tabrizi L, Mohammadi S. ...
  • Potdar D, Hirwani RR, Dhulap S. Phyto-chemical and pharmacological applications ...
  • Ashraf H , Heidari R, Nejati V IM. Preventive effect ...
  • Ashraf H, Zare S. Preventive effects of aqueous extract of ...
  • Chang W, Chen L, Hatch GM. Berberine as a therapy ...
  • Mohammadi A, Gholamhosseinian A, Fallah H. Trigonella foenum-graecum water extract ...
  • Shih CC, Lin CH, Lin WL, Wu J Bin. Momordica ...
  • Elrashidy R, Asker M. Pioglitazone attenuates cardiac fibrosis and hypertrophy ...
  • Gholamhoseinian A, Falah H, SHarififar F. Anti-hyperglycemic activity of four ...
  • Kangani C, Kelley D, DeLany J. New method for GC/FID ...
  • Abdin AA, Baalash AA, Hamooda HE. Effects of rosiglitazone and ...
  • Paradis S, Cabanac M, Marceau P, Frankham P. Body weight ...
  • Lee YS, Cha BY, Choi SS, Choi BK, Yonezawa T, ...
  • Liu X, Li G, Zhu H, Huang L, Liu Y, ...
  • Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type ۲ ...
  • Bambace C, Telesca M, Zoico E, Sepe A, Olioso D, ...
  • Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between ...
  • Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma ...
  • Natali A, Natali A, Ferrannini E, Ferrannini E. Effects of ...
  • Papaetis GS, Orphanidou D, Panagiotou TN. Thiazolidinediones and type ۲ ...
  • Elmazar MM, El-Abhar HS, Schaalan MF, Farag NA. Phytol/Phytanic acid ...
  • Sakamoto J, Kimura H, Moriyama S, Odaka H, Momose Y, ...
  • Ye JM, Tid-Ang J, Turner N, Zeng XY, Li HY, ...
  • Derosa G, Maffioli P. Peroxisome proliferator-activated receptor- γ ( PPAR- ...
  • Olson AL. Insulin resistance: cross-talk between adipose tissue and skeletal ...
  • Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights ...
  • نمایش کامل مراجع